The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA).
Martina FrodlundPer NivedKaterina ChatzidionysiouAnna SödergrenEva KlingbergMonica HanssonSophie OhlssonElisa PinAnders BengtssonLars KlareskogMeliha Crnkic KapetanovicPublished in: Microbiology spectrum (2024)
EudraCT (European Union Drug Regulating Authorities Clinical Trials Database) with number 2021-000880-63.